Literature DB >> 23275842

Ocular complications of leprosy in yemen.

Raga A A Salem1.   

Abstract

OBJECTIVES: This study was conducted to identify the main ocular- and vision-threatening complications of leprosy in Yemen.
METHODS: This is a cross-sectional observational study which took place from February to July 2010. Leprosy patients attending the Skin and Venereal Diseases Hospital in the City of Light in Taiz, Yemen, who consented to participate in the study, were enrolled. Detailed demographic and medical histories were taken and clinical examination findings were recorded. A detailed eye examination, including visual acuity (VA), slit-lamp, and fundus examinations, was conducted on each patient by a qualified ophthalmologist.
RESULTS: A total of 192 patients (180 male, 12 female, with a male to female ratio of 15:1) were included in the study. The majority of the patients (157; 81.8%) were over 40 years. Over two-thirds of the patients (129; 67.2%) had had leprosy for more than 20 years. Ocular complications were found in 97% of cases; 150 (39.1%) of the patients' eyes had at least one pathology. Eyelid involvement was the most common problem observed in 102 (26.5%) patients. Half of the eyes (192; 50%) had a VA of <6/60. The main cause of blindness among these patients was corneal opacity detected in 69 out of 192 patients (35.9%).
CONCLUSION: Ocular complications are frequent among leprosy patients in Yemen. They are true vision-threatening lesions. It is important to prevent these lesions through early diagnosis and adequate treatment.

Entities:  

Keywords:  Blindness; Corneal opacity; Eyelid; Leprosy; Yemen

Year:  2012        PMID: 23275842      PMCID: PMC3523995     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  23 in total

1.  Ocular findings in leprosy patients in Nepal in the era of multidrug therapy.

Authors:  Bhagavat P Nepal; Ujjowala D Shrestha
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

2.  Dermatologists combat leprosy in Yemen.

Authors:  Y al-Qubati; A S al-Kubati
Journal:  Int J Dermatol       Date:  1997-12       Impact factor: 2.736

3.  Leprosy blindness in Nepal.

Authors:  Himanshu Ravi Gupta; Suraj Shakya; Mahesh Shah; Heera Mana Pradhan
Journal:  Nepal Med Coll J       Date:  2006-06

4.  Ocular leprosy in South Vietnam.

Authors:  A Hornblass
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

5.  Ocular involvement from leprosy.

Authors:  P A Lamba; D S Kumar
Journal:  Indian J Ophthalmol       Date:  1984 Mar-Apr       Impact factor: 1.848

6.  Unexpected findings amongst the skin test responses to mycobacteria of BCG vaccinated Kuwaiti school children.

Authors:  G M Bahr; T D Chugh; K Behbehani; M A Shaaban; M Abdul-Aty; B Al Shimali; Z Siddiqui; M Gabriel; G A Rook; J L Stanford
Journal:  Tubercle       Date:  1987-06

7.  Leprosy in Kuwait: an epidemiological study of new cases.

Authors:  S al-Kandari; A al-Anezi; R N Pugh; F al-Qasaf; S al-Abyad
Journal:  Ann Trop Med Parasitol       Date:  1990-10

8.  Changing demography of leprosy: Kuwait needs to be vigilant.

Authors:  Nawaf Al-Mutairi; Azari Al-Doukhi; Mahmoud S Ahmad; Mohamed El-Khelwany; Ahmad Al-Haddad
Journal:  Int J Infect Dis       Date:  2010-08-08       Impact factor: 3.623

9.  Ocular findings in leprosy patients in an institution in Nepal (Khokana).

Authors:  O K Malla; F Brandt; J G Anten
Journal:  Br J Ophthalmol       Date:  1981-04       Impact factor: 4.638

10.  Cataract surgery in the management of the late complications of lepromatous leprosy in South Korea.

Authors:  T J Ffytche
Journal:  Br J Ophthalmol       Date:  1981-04       Impact factor: 4.638

View more
  2 in total

1.  A rare cause of acquired esotropia: Leprosy.

Authors:  Mehmet Canleblebici; Hakan Yildirim; Mehmet Balbaba; Orhan Aydemir
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

2.  The clinical & neurophysiological study of leprosy.

Authors:  Murat Cabalar; Vildan Yayla; Samiye Ulutas; Songul Senadim; Ayla Culha Oktar
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.